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Abstract
Autophagy is a highly orchestrated intracellular bulk degradation process that is activated by various environmental
stresses. The serine/threonine kinase ULK1, like its yeast homologue Atg1, is a key initiator of autophagy that is negatively
regulated by the mTOR kinase. However, the molecular mechanism that controls the inhibitory effect of mTOR on ULK1-
mediated autophagy is not fully understood. Here we identified AMPK, a central energy sensor, as a new ULK1-binding
partner. We found that AMPK binds to the PS domain of ULK1 and this interaction is required for ULK1-mediated autophagy.
Interestingly, activation of AMPK by AICAR induces 14-3-3 binding to the AMPK-ULK1-mTORC1 complex, which coincides
with raptor Ser792 phosphorylation and mTOR inactivation. Consistently, AICAR induces autophagy in TSC2-deficient cells
expressing wild-type raptor but not the mutant raptor that lacks the AMPK phosphorylation sites (Ser722 and Ser792).
Taken together, these results suggest that AMPK association with ULK1 plays an important role in autophagy induction, at
least in part, by phosphorylation of raptor to lift the inhibitory effect of mTOR on the ULK1 autophagic complex.
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Introduction
Autophagy is an intracellular catabolic system that delivers
cytoplasmic contents (e.g., proteins, lipids, and organelles) to
lysosomes for degradation [1]. There are three major pathways of
autophagy in eukaryotic cells, namely macroautophagy, microauto-
phagy, and chaperone-mediated autophagy. Macroautophagy
(referred to as autophagy hereafter) involves de novo formation of
double-membrane vesicles, termed autophagosomes, which engulf
intact organelles (such as mitochondria) and portions of the cytosol.
The outer membrane of the autophagosome fuses with an endosome
and/or lysosome to form an autolysosome where cytoplasm-derived
materials, together with the inner membrane of the autophagosome,
are degraded by lysosomal hydrolases. The resulting macromole-
cules are transported back to the cytosol as an internal source of
nutrients to support energy production or biosynthesis. This self-
digestion process is well conserved from yeast to human and has an
impact on development, immune defense, programmed cell death,
neurodegeneration, cancer, and aging [1,2].
Target of rapamycin (TOR) is a serine/threonine protein kinase
involved in regulating cell growth and metabolism [3]. Accumulating
evidence indicates that TOR, as well as its mammalian homologue
mTOR, functions as the major inhibitory controller of autophagy in
the presence of growth factors and abundant nutrients [4]. Rapamycin,
an inhibitor of TOR can induce autophagy even under nutrient rich
conditions. In mammalian cells, mTOR is part of two structurally and
functionally distinct multiprotein complexes termed mTORC1
(containing mTOR, GbL, PRAS40, and raptor), which is highly
sensitive to rapamycin and cellular nutrient availability, and mTORC2
(containing mTOR, GbL, mSin1, and rictor), which is insensitive to
rapamycin [3,5]. Raptor is an essential protein for mTOR signaling
that acts positively in mTORC1 as scaffold for recruiting downstream
substrates such as ribosomal S6 kinase (p70S6K1) and eukaryotic
initiation factor 4E binding protein 1 (4EBP1) to the mTORC1
complex. While nutrient-rich conditions activate mTORC1 through
the small GTPase Rheb, nutrient-poor conditions inactivate
mTORC1 through AMP-activated protein kinase (AMPK).
AMPK is a central metabolic sensor found in all eukaryotes that
governs glucose and lipid metabolism in response to alterations in
nutrients and intracellular energy levels. This serine/threonine kinase,
which is a heterotrimer composed of a catalytic (AMPKa) subunit and
two regulatory (AMPKb and AMPKc) subunits, is activated through
the upstream kinase LKB1 when intracellular ATP levels decline and
AMP levels increase, such as during nutrient and energy depletion or
hypoxia [6]. Active AMPK directly phosphorylates the TSC2 tumor
suppressor, leading to the inactivation of Rheb, which directly binds to
and activates the mTORC1 kinase [7,8]. Alternatively, a recent study
indicated that AMPK regulates mTOR signaling by directly
phosphorylating raptor on two conserved serine residues Ser722 and
Ser792 [9]. The phosphorylation of raptor by AMPK induces 14-3-3
binding to raptor, which is required for the inhibition of mTORC1
and cell cycle arrest induced by energy stress [9].
The serine/threonine kinase Atg1 was the first autophagy
regulator identified by genetic screens in yeast for essential
autophagy genes [10]. Atg1 interacts with the autophagy
regulatory proteins Atg13 and Atg17, and this complex is thought
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sphorylated in a TOR-dependent manner under nutrient-rich
conditions and is rapidly dephosphorylated after nutrient starva-
tion or rapamycin treatment, which enhances its interaction with
Atg1. Both Atg13 and Atg17 are required for Atg1 kinase activity,
autophagy induction, and cytoplasm-to-vacuole targeting [12]. In
Drosophila, Atg1 physically interacts with TOR and Atg13, and
both Atg1 and Atg13 are phosphorylated in a TOR- and Atg1-
dependent manner under nutrient-rich conditions [13]. In contrast
to yeast, Drosophila Atg13 is hyperphosphorylated under autoph-
agic conditions, primarily via an Atg1-dependent pathway [13]. In
mammals, there are two Atg1 homologues, UNC-51-like kinase 1
and 2 (ULK1 and ULK2). While ULK1 plays an important role in
the regulation of autophagy, the function of ULK2 in autophagy
has not been clearly defined. Similarly to yeast Atg1, ULK1 forms
a complex with mammalian Atg13 (mAtg13) and FIP200, the
functional analog of yeast Atg17 [14,15,16]. In this complex,
mAtg13 mediates the interaction between FIP200 and ULK1 and
is required for the phosphorylation of FIP200 by ULK1 in
response to starvation [15]. Moreover, FIP200 is required for the
stability and full kinase activity of ULK1 [14,16].
Interestingly, it has recently been shown that mTORC1
associates with the ULK1-mAtg13-FIP200 complex through an
interaction between raptor and ULK1 and phosphorylates ULK1
and mAtg13 to repress the kinase activity of ULK1, thereby
suppressing the initiation of autophagy [15,16,17]. However, the
mechanismbywhichmTOR iscontrolledtoactivateULK1activity
for autophagy induction has not yet been clearly elucidated.
In this study, we have identified AMPK as a new ULK1-binding
protein and demonstrated that raptor phosphorylation by AMPK
plays an important roleinautophagyinduction,presumablythrough
the suppression of the inhibitory effect of mTORC1 on the ULK1
autophagic complex under nutrient or energy stress conditions.
Results
Identification of AMPK as an ULK1-binding protein
To date, several ULK1-interacting proteins have been reported
in mammals, including GABARAP, GATE-16, SynGAP, Synte-
nin, mAtg13, FIP200, Atg101, p62/SQSTM1, and mTORC1
[14,15,16,17,18,19,20,21]. To gain further insight into the
mechanism of action of ULK1, we took a proteomics approach
combined with tandem affinity purification (TAP) [22] to identify
additional ULK1-binding protein(s) in 293 cells stably transfected
with TAP-ULK1. Tandem mass spectrometry (MS/MS) analysis
of the ULK1 immune complexes revealed AMPKc1, an AMPK
subunit, as a new ULK1-binding protein (data not shown). AMPK
is a heterotrimeric complex composed of a catalytic subunit
(AMPKa) and two regulatory subunits (AMPKb and AMPKc),
and each subunit exists as different isoforms (a1, a2, b1, b2, c1,
c2, c3). During preparation of this manuscript for publication,
Behrends et al [23] reported a detection of the catalytic and
regulatory subunits of AMPK in ULK1 as well as ULK2
immunocomplexes by proteomic analysis. Consistently, all three
endogenous AMPK subunits (AMPKa, AMPKb, and AMPKc)
were confirmed to associate with HA-ULK1 in 293 cells by co-
immunoprecipitation analysis (Fig. 1A). The interaction between
AMPK and ULK1 was further confirmed in 293T cells co-
transfected with Flag-AMPKa2 and HA-ULK1 (Fig. 1B). We also
observed an association between endogenous ULK1 and Flag-
tagged AMPKa2 or AMPKb1 (Fig 1C). Moreover, endogenous
ULK1 was co-immunoprecipitated with endogenous AMPKa in
293T cells (Fig 1D). This interaction is specific, as knockdown of
ULK1 abrogated co-immunoprecipitation of ULK1 with AMPK
(Fig 1E). In addition, purified recombinant His6-tagged AMPKa/
b/c subunits could form a complex with purified recombinant
His6-ULK1 but not His6-Bcl-XL proteins in vitro, suggesting that
the interaction between AMPK and ULK1 is a direct and specific
association (Fig. 1F). Taken together, these data indicate that
AMPK is a new binding partner for ULK1.
AMPK binds to the PS domain of ULK1
To determine which region of ULK1 is required for its
interaction with AMPK, we generated a series of ULK1 deletion
mutants. Co-immunoprecipitation analyses revealed that AMPK
binds to amino acids 654–828 within the proline-serine rich (PS)
domain of ULK1 (Fig. 2A–C). However, in contrast to the previous
report [17], the mTORC1-binding site was mapped to the kinase
domain (amino acids 1–278) of ULK1 (Fig. 2A, B). Moreover,
AMPK, Raptor and mTOR could interact with both wild type and
kinase-dead mutant (K46N) of ULK1 (Fig. 2B), suggesting that the
kinase activity is not required for ULK1 to interact with AMPK and
mTORC1. Taken together, our results indicate that AMPK binds
to the PS domain of ULK1, whereas mTORC1 associates with
ULK1 through raptor binding to the kinase domain of ULK1.
The AMPK binding domain is required for ULK1 to induce
autophagy
To determine whether the AMPK-ULK1 interaction regulates
autophagy, we generated a deletion mutant ULK1 (D654–828)
that lacks the AMPK binding domain but retains the ability to
interact with mTORC1 (Fig. 3A). Transfection of mouse ULK1
into U-2OS cells expressing shRNA targeting human ULK1
restored GFP-LC3 punctate foci formation (a well-characterized
marker of autophagosomes) induced by the AMPK activator
metformin (Fig. 3B, C). In contrast, expression of the ULK1
(D654–828) mutant failed to restore metformin-induced autopha-
gosome formation in ULK1 knockdown U-2OS cells (Fig. 3B, C).
Moreover, overexpression of the AMPK-binding ULK1 fragment
in U-2OS cells suppressed GFP-LC3 punctate foci formation in a
dose-dependent manner after nutrient starvation (Fig. 3D).
Collectively, these observations indicate that AMPK binding to
ULK1 plays an important role in the induction of autophagy.
Recruitment of 14-3-3 to the ULK1-mTORC1 complex
upon AMPK activation
Since AMPK associates with the ULK1-mTORC1 complex and
14-3-3 binding to raptoriscritical for AMPK inhibition ofmTORC1
[9], we next examined whether 14-3-3 is recruited to the ULK1
complex upon AMPK activation. As shown in Fig. 4, activation of
AMPK by AICAR resulted in the recruitment of 14-3-3t to the
ULK1-mTORC1 complex, which correlates with the levels of
ULK1-bound Ser792 phosphorylated raptor. AICAR-induced
AMPK activation and mTORC1 inactivation were determined by
measuring ACC (Ser79) phosphorylation and S6K (Thr389)
dephosphorylation, respectively. Although AICAR treatment mod-
estly caused PRAS40 dephosphorylation and 14-3-3 dissociation
(data not shown), it has been demonstrated that PRAS40 association
is not the key event dictating the impact of raptor phosphorylation on
mTORC1 kinase activity [9]. Taken together, these results suggest
that activation of AMPK by energy stress recruits 14-3-3 to raptor,
thereby inhibiting the mTORC1 activity in the ULK1 complex.
AMPK phosphorylation of raptor regulates autophagy
induction
Although AMPK activation was shown to suppress autophagy
in hepatocytes [24], it is generally agreed that AMPK is required
The AMPK-ULK1-mTORC1 Complex
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15394Figure 1. AMPK interacts with ULK1 directly. (A) 293T cells were transfected with Flag-ULK1 or control empty vector and subjected to
immunoprecipitation with anti-Flag antibody, followed by immunoblot analysis with the indicated antibodies. (B) 293T cells were co-transfected with
Flag-AMPKa2 and HA-ULK1. Cell lysates were subjected to immunoprecipitation using anti-Flag antibody followed by SDS-PAGE/immunoblot analysis
with anti-HA and anti-Flag antibodies. (C) 293T cells were transiently transfected with Flag-AMPKa2 or Flag-AMPKb1. After 24 h, immunoprecipitation
was performed using anti-Flag or control anti-HA antibodies and analyzed by immunoblotting with anti-ULK1 and anti-Flag polyclonal antibodies. (D)
293T cell lysates were subjected to immunoprecipitation with anti-ULK1 polyclonal antibody or control preimmune rabbit serum (NRS), followed by
immunoblot analysis with anti-ULK1 and anti-AMPKa antibodies. (E) 293T cells were infected with ULK1 shRNA or control shRNA lentiviruses and
The AMPK-ULK1-mTORC1 Complex
PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15394Figure 2. AMPK and mTORC1 interact with ULK1 through the PS domain and the kinase domain of ULK1, respectively. (A) A schematic
ofULK1illustratingitskinasedomain,proline/serine-richdomain,C-terminal(CT)domain,andregionsforbindingtoAMPKandmTORC1.(B,C)293Tcells
were transfected with empty vector or HA-tagged wild type (WT) or deletion mutants of ULK1 and subjected to immunoprecipitation with anti-HA
antibody. The resulting immune complexes were analyzed by immunoblotting with antibodies specific for mTOR, raptor, AMPKa or HA-tag.
doi:10.1371/journal.pone.0015394.g002
subjected to immunoprecipitation with control rabbit IgG or anti-AMPKa antibody followed by immunoblotting with anti-ULK1 and anti-AMPKa
antibodies. (F) Purified His6-AMPKa1/b1/c1 fusion proteins (250 ng) were mixed with purified His6-tagged ULK1 (1 mg) or Bcl-XL (200 ng) proteins in
1% Triton X-100 lysis buffer containing protease inhibitors and subjected to immunoprecipitation with anti-ULK1 antibody. The resulting protein
complexes and 10% of the input proteins were analyzed by immunoblotting with anti-His-Tag polyclonal antibody.
doi:10.1371/journal.pone.0015394.g001
The AMPK-ULK1-mTORC1 Complex
PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e15394Figure 3. The AMPK-ULK1 interaction is important for ULK1-mediated autophagy. (A) 293T cells were transfected with empty vector or
HA-tagged wild type (WT) or deletion mutant (D654–828) ULK1 and subjected to immunoprecipitation with anti-HA antibody followed by
immunoblotting with the indicated antibodies. (B) U-2OS cells stably expressing GFP-LC3 were infected with lentivirus expressing human Ulk1 shRNA
(shhUlk1) or scrambled shRNA (shScr) and subjected to selection with 1 mg/ml puromycin for 5 days. The cells were then transfected with wild type
mouse Ulk1 (mUlk1), mUlk1 D654–828 or control empty vector for 24 h, incubated in serum-free DMEM overnight, and cultured in complete medium
with or without 10 mM metformin for 20 h. The images were obtained using a fluorescence microscope. The scale bars represent 10 mm. (C) The
number of GFP-LC3 dots per GFP-positive cell in (B) was quantified (mean 6 s.d.; n=81). (D) U-2OS cells stably expressing GFP-LC3 were transfected
with 0, 2 or 4 mg of pcDNA3 encoding HA-tagged ULK1 deletion mutant (554–828). The total amount of plasmid DNA used for each transfection was
normalized at 4 mg with empty vector. After 24 h transfection, the cells were starved in nutrient-free medium for 1.5 h, fixed in 4% paraformaldehyde,
and analyzed by fluorescence microscopy. The number of GFP-LC3 dots per GFP-positive cell was quantified (mean 6 s.d.; n=100). Statistical
significance was determined by Student’s t-test and the asterisks indicate P,0.0001.
doi:10.1371/journal.pone.0015394.g003
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raptor by AMPK is important for autophagy induction, we utilized
TSC2-deficient MEF cells in which endogenous raptor was stably
replaced with human wild type raptor or mutant raptor (S722A/
S792A, henceforth referred to as the AA mutant) lacking AMPK
phosphorylation sites as described previously [9]. The wild type
raptor and AA mutant raptor cells were transfected with GFP-LC3
and treated with AICAR to activate AMPK. Autophagy was
evaluated by the formation of GFP-LC3 dots. While the TSC2-
deficient MEF cells with wild type raptor showed a drastic increase
in the number of GFP-LC3 dots per GFP-positive cell following
AICAR treatment, the cells expressing the AA mutant raptor had
only a few detectable GFP-LC3 dots even after AICAR treatment
(Fig 5A, B). In addition to LC3, p62/SQSTM1 is another widely
used marker for autophagic flux. It has been shown that the steady
state levels of p62 reflect autophagic activity [26,27]. To examine
the effect of raptor phosphorylation by AMPK on autophagic flux,
we monitored p62 degradation in these cells during AICAR
treatment. Immunoblot analysis revealed that autophagic flux was
suppressed in TSC2-deficient cells with the AA mutant raptor
(Fig. 5C). Consistent with a previous report [9], AICAR induced
raptor (Ser792) phosphorylation and suppressed mTOR activity,
as measured by S6K (Thr389) phosphorylation, in TSC2-deficient
cells reconstituted with wild type raptor but not the AA mutant
raptor (Fig. 5C). Therefore, these data suggest that AMPK-
mediated phosphorylation of raptor is important for autophagy
induction, presumably through activation of ULK1 by suppressing
the mTORC1 inhibitory activity.
Discussion
In this study, we have demonstrated that AMPK binds to the PS
domain of ULK1, which plays a vital role in ULK1-mediated
autophagy. Our findings suggest that AMPK may activate ULK1
for autophagy induction through the inhibition of mTORC1
activity by phosphorylation of raptor in the ULK1 autophagic
complex (Fig. 5D). It has been reported that AMPK can suppress
mTORC1 signaling through direct phosphorylation of TSC2 and
raptor [7,9]. Interestingly, FIP200, an ULK1-binding protein, has
been demonstrated to interact with the TSC1/TSC2 complex
through TSC1 [28]. Thus, it remains to be determined whether
TSC1/TSC2 exist in the ULK1 complex and, if so, whether
AMPK inhibits the mTORC1 activity not only through
phosphorylation of raptor but also through phosphorylation of
TSC2 in the ULK1-mTORC1 complex.
In yeast, the ability of Atg13 binding to Atg1 is regulated by its
phosphorylationstatus [12]. While Atg13 is hyperphosphorylated in
a TOR-dependent manner under nutrient-rich conditions, it is
rapidly dephosphorylated under nutrient-poor conditions. The
dephosphorylation of Atg13 enhances its binding to Atg1. Atg17
interacts with Atg1 through Atg13 and both Atg13 and Atg17 are
required for Atg1 kinase activity, autophagy induction, and
cytoplasm-to-vacuole targeting [12,29]. In mammalian cells,
however, ULK1 forms a stable protein complex with mAtg13 and
FIP200 regardless of nutrient conditions [17]. Interestingly,
mTORC1 dissociates from the ULK1-mAtg13-FIP200 complex
under nutrient starvation conditions, and this dissociation was
speculated to be the key event leading to ULK1 activation and
autophagy induction [17]. Thus, it is possible that AMPK
phosphorylation of raptor and subsequent recruitment of 14-3-3
to raptorcause mTORC1 dissociationfrom theULK1 multiprotein
complex. It is also possible that AMPK phosphorylates ULK1,
resulting in a conformational change that interferes with the
interaction between ULK1 and mTORC1. Alternatively, AMPK
may activate ULK1 for autophagy induction through direct
phosphorylation of ULK1. Indeed, purified AMPK kinase could
phosphorylate recombinant ULK1 protein in vitro (data not shown).
The role of AMPK in autophagy regulation remains controver-
sial. It has been shown that activation of AMPK by AICAR blocks
autophagy in hepatocytes [24,30]. In contrast, many studies suggest
that pharmacological activation of AMPK by compounds, such as
AICAR and metformin, induces autophagy in an AMPK-
dependent manner [25,31,32,33,34]. Moreover, a recent report
has demonstrated that raptor phosphorylation by AICAR-activated
AMPK is required for cell cycle arrest through suppression of
mTORC1 activity [9]. Consistent with these observations, our
studies provide evidence that raptor phosphorylation by AMPK
plays a role in autophagy induction, presumably through suppres-
sion of mTORC1 anti-autophagic activity in the ULK1 complex.
In addition, a recent study has proposed that the ULK1 complex
functionsinthe regulationofmTORC1activity[15].Up-regulation
of S6K1 phosphorylation at Thr389, an indicator of mTORC1
activity, was observed in mAtg13, ULK1 or ULK2 knockdown cells
[15]. This result is also supported by previous findings that
overexpression of Atg1 in Drosophila fat body has a negative effect
on S6K1 phosphorylation and knockdown of ULK1 or ULK2 in
mammalian cells increases S6K1 phosphorylation [35,36]. Thus, it
will be interesting to determine whether AMPK collaborates with
ULK1 in the regulation of S6K1 through phosphorylation of raptor
in the context of cell growth control and autophagy.
In conclusion, we have identified a new ULK1-binding protein,
AMPK, which is an energy sensor coupled to cell growth control.
AMPK associates with the ULK1-mTORC1 complex and
promotes autophagy, at least in part, by inhibiting mTOR
through phosphorylation of raptor in the ULK1 autophagic
complex. Clearly, future studies are needed to further demonstrate
whether AMPK also regulates mAtg13 or FIP200, such as
phosphorylation, in the ULK1-mAtg13-FIP200 complex and
Figure 4. AICAR induces AMPK phosphorylation of raptor and
the recruitment of 14-3-3 to the ULK1-mTORC1 complex. 293
cells stably expressing HA-ULK1 were treated with 1 mM AICAR for the
indicated times and subjected to immunoprecipitation with anti-HA or
control anti-FLAG antibodies. The resulting immune complexes were
analyzed by immunoblotting with the indicated antibodies.
doi:10.1371/journal.pone.0015394.g004
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by AMPK. Moreover, we found that AMPK can phosphorylate
ULK1 (data not shown). Therefore, further investigation of the
interaction and phosphorylation regulation between ULK1 and
AMPK will facilitate our knowledge on the mechanisms of the
AMPK-ULK1-mTORC1 complex in autophagy induction and
autophagy-associated diseases including cancer and neurodegen-
eration.
Figure 5. Raptor phosphorylation by AMPK is required for AICAR-induced autophagy in TSC2
2/2 MEF cells. (A) TSC2
2/2, p53
2/2 MEFs
stably reconstituted with wild-type raptor or S722A/S792A mutant raptor were transfected with GFP-LC3, treated with 2 mM AICAR or control vehicle
for 4 h, and then analyzed by fluorescent microscopy. The number of GFP-LC3 dots per GFP-positive cell was counted (mean 6 s.d.; n=60). The scale
bars represent 10 mm. (B) TSC2
2/2, p53
2/2 MEFs stably reconstituted with wild-type raptor or S722A/S792A mutant raptor were treated with 2 mM
AICAR for the indicated times. Cell lysates were prepared in RIPA buffer and analyzed by immunoblotting with the indicated antibodies. The levels of
p62 are listed relative to those of untreated WT raptor cells, which were set as 1. (C) Schematic representation of AMPK-mediated suppression of the
inhibitory effect of mTORC1 on the ULK1 autophagic complex.
doi:10.1371/journal.pone.0015394.g005
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Chemical and Antibodies
Polyclonal anti-ULK1 antibody (A7481), monoclonal anti-b-actin
antibody (A2228), and monoclonal anti-FLAG M2-agarose (A2220)
were purchased from Sigma. Antibodies against AMPKa (2532),
AMPKb1 (4182), AMPKc1 (4187), mTOR (2972), raptor (2280),
phospho-raptor S792 (P-Raptor; 2083), p70 S6 kinase (S6K; 9202),
phospho-S6K T389 (P-S6K; 9205), phospho-Acetyl-CoA carboxyl-
ase (P-ACC; 3661), and 14-3-3t (9638) were purchased from Cell
Signaling Technology. Anti-HA monoclonal antibody (HA.11;
MMS-101P) and anti-c-Myc monoclonal antibody (9E10) were from
Covance and EMD Biosciences, respectively. Guinea pig polyclonal
anti-p62 antibody was purchased from American Research Products
(03-GP62-C). Metformin (D150959) and 5-aminoimidazole-4-car-
boxyamide ribonucleoside (AICAR; A611700) were obtained from
Sigma and Toronto Research Chemicals, respectively. Purified His6-
tagged AMPKa1/b1/c1 proteins (7439) were purchased from Cell
Signaling Technology. Recombinant His6-ULK1 and His6-Bcl-XL
fusion proteins were purified in E. coli by Ni-NTA column
chromatography. Anti-His-Tag polyclonal antibody (A00174) was
purchased from GenScript.
DNA Constructions
Mouse ULK1 cDNA clones were kindly provided by Dr.
Masaaki Muramatsu (Tokyo Medical and Dental University). Both
full-length and fragments of mouse ULK1 cDNA were obtained by
PCR amplification and subcloned into pcDNA3-HA vector.
Human PRKAA2 (AMPKa2; 7262537) and PRKAB1 (AMPKb1;
3884583) cDNA clones were obtained from Open Biosystems and
subcloned into p3xFLAG-CMV10 vector (Sigma). The kinase-dead
mutant of ULK1 (K46N) was made using site-directed mutagenesis
kit (Stratagene). The pLKO.1-based lentiviral shRNAs targeting
human ULK1 (TRCN0000000835) were purchased from Open
Biosystems. The scrambled shRNA was obtained from Addgene.
Cell Culture and Transfection
TSC2
2/2, p53
2/2 MEF cell lines in which endogenous murine
raptor was replaced with human wild type raptor or mutant raptor
(S722A/S792A) lacking AMPK phosphorylation sites [9] were
kindly provided by Dr. Reuben J. Shaw (Salk Institute, La Jolla,
CA). All other cell lines were purchased from ATCC. 293, 293T,
MEF, and U-2OS cells were cultured in Dulbecco’s Modified Eagle
Mediumat 37uCi n5 %C O 2. Mediumwassupplemented with 10%
fetal bovine serum (FBS) and 1x penicillin/streptomycin. For
transient expression of proteins, 293T cells were transfected with
recombinant DNA plasmids using Lipofectamine 2000 (Invitrogen;
11668-019) following manufacturer’s protocol. Cells were harvested
2 days after transfection for co-immunoprecipitation assay or
Western blot analysis. For establishment of stable cell lines, 293 and
U-2OS cells were transfected with pcDNA3-HA-ULK1 or pEGFP-
LC3 plasmid, respectively, using Lipofectamine 2000 and selected
by culturing in the presence of 600 mg/ml Geneticin (Invitrogen;
10131-035). For starvation treatment, cells were washed with
phosphate-buffered saline (PBS) and incubated in amino acid-free
DMEM without FBS (starvation medium).
Tandem Affinity Purification of ULK1-binding Protein
The ULK1 cDNA was subcloned into the EcoRI site of
pcDNA3.4-N-R1 TAP vector [37]. The amino-terminal TAP-
tagged ULK1 was stably expressed in 293 cells. After starvation in
Earle’sbalanced saltsolution (EBSS)for2 hours,thecellswerelysed
in cell lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1%
Triton X-100, 2 mM EGTA, 10 mM NaF, 1 mM Na3VO4,a n d
protease inhibitors). The cell lysate was subjected to purification/
mass spectrometry analysis as described previously [22,37].
Immunoprecipitation and Immunoblotting
Cell lysates were prepared in a 0.5% Triton X-100 lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5%
Triton X-100, 1 mM PMSF, 1 mM Na3VO4) containing a
protease inhibitor cocktail (Roche; 11873580001) and phosphatase
inhibitor cocktails 1/2 (Sigma; P2850/P5726). The clarified lysates
were subjected to immunoprecipitation using specific antibodies in
combination with protein A or G Sepharose (GE Healthcare). The
resulting immunocomplexes were washed three times with lysis
buffer and boiled in SDS-sample buffer. Immunoprecipitation for
the mTORC1-ULK1 association was performed with a 0.3%
CHAPS lysis buffer (40 mM HEPES, pH 7.4, 2 mM EDTA,
10 mM sodium-pyrophosphate, 10 mM glycerophosphate, 0.3%
CHAPS, protease inhibitor cocktail, and phosphatase inhibitor
cocktails 1/2) and a wash buffer (40 mM HEPES, pH 7.4,
150 mM NaCl, 2 mM EDTA, 10 mM pyrophosphate, 10 mM
glycerophosphate, and 0.3% CHAPS) as described previously
[38,39]. Samples were subsequently separated by SDS-PAGE and
transferred onto nitrocellulose membranes (Bio-Rad). Immunoblot
analysis was performed with the indicated antibodies and
visualized with Super-Signal West Pico Chemiluminescent sub-
strate (Pierce Chemical).
Analysis of Autophagy by Fluorescence Microscopy
TSC2
2/2, p53
2/2 MEF cells containing wild-type or S722A/
S792A mutant raptor were transfected with GFP-LC3 plasmid
using Amaxa Nucleofector NHDF kits (Lonza; F-06720) and
cultured in 4-well chamber slide (Nunc; 154917). After 24 h
transfection, the cells were treated with 2 mM AICAR for 4 h,
fixed with 4% paraformaldehyde in PBS for 15 min, and mounted
using ProLong Gold antifade reagent with DAPI (Invitrogen;
P36935). Images were acquired on Olympus microscope (Olym-
pus; IX81) coupled to the Slidebook 5.0 software.
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